http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#Head
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#assertion
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#provenance
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#pubinfo
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#assertion
http://purl.obolibrary.org/obo/DOID_11204
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_11204
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00741
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#association
http://www.w3.org/2000/01/rdf-schema#label
cortef tablets are indicated in the following conditions primary or secondary adrenocortical insufficiency hydrocortisone or cortisone is the first choice synthetic analogs may be used in conjunction with mineralocorticoids where applicable in infancy mineralocorticoid supplementation is of particular importance as adjunctive therapy for short term administration to tide the patient over an acute episode or exacerbation in psoriatic arthritis during an exacerbation or as maintenance therapy in selected cases of systemic lupus erythematosus pemphigus control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment seasonal or perennial allergic rhinitis severe acute and chronic allergic and inflammatory processes involving the eye and its adnexa such as allergic conjunctivitis symptomatic sarcoidosis idiopathic thrombocytopenic purpura in adults for palliative management of leukemias and lymphomas in adults to induce a diuresis or remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus to tide the patient over a critical period of the disease in ulcerative colitis acute exacerbations of multiple sclerosis tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB00741
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#provenance
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#pubinfo
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#sig
http://purl.org/nanopub/x/hasSignature
FZoHTPax2uDDVQfVpl+3wAJ7KPPAAvAMQrveb3/oO9ZSN7+umeU/dxcekB3zfmHb7ZuhcW+j3dr7zrw+gT/Vf0YpI9b/VSd5nrABaAwjKt2M7dvT/BWlsxu/en3BrpKC7MeuFwSj417cniPTB6nP7XDCfVzE4jvSRTKNMo/xJ04=
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk
http://purl.org/dc/terms/created
2021-06-27T19:56:47.161+02:00
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAOOt7M2x5-LwRTZ27B9AfxI6jSmFVxBKhIYdXdQzZpGk
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs